Relevance of metabolic syndrome and its definition depending on the criteria employed;Importancia del síndrome metabólico y de su definición dependiendo de los criterios utilizados

Medicina Clinica

Volumn 124, Issue 10, 2005, Pages 376-378

  Real, José T ^a   Carmena, Rafael ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; EDITORIAL; EDUCATION PROGRAM; HEALTH EDUCATION; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; METABOLIC SYNDROME X; OBESITY; STANDARD;

EID: 17144376825     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13072572     Document Type: Editorial

References (22)

1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-607.
2. Hanefeldt M, Leonhardt W. The metabolic syndrome. Jena: G. Fischer, 1997; p. 13-24.
3. Ferrannini E, Haffner S, Mitchell B, Stern M. Hyperinsulmemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia. 1991;34:411-22.
4. Reaven G. Role of insulin resistanse in human disease (syndrome X) expanded definition. Ann Rev Med. 1993;44:121-31.
5. Alexander C, Landsman P, Teutsch S, Haffner S. NCEP-defined metabolic syndrome, diabetes and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes. 2003;52: 1210-6.
6. Lakka HM, Laakssonen D, Laaka T, Niskanen L, Kumpusalo E, Tuomileto J, et al. The metabolic syndrome and total and cardiovascular mortality in middle aged men. JAMA. 2002;288:2709-16.
7. Laaksonen D, Lakka HM, Niskanen L, Kaplan G, Salonen J, Lakka T. Metabolic syndrome and development of diabetes: applications and validation of recent suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol. 2002;156:1070-7.
8. NHO. Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO consultation. Geneva: Department of Noncomunicable Disease Surveillance, Word Health Organization, 1999.
9. Executive summary of the third report of the National Cholesterol Education (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Cholesterol in Adults (Adults Treatment Panel III). JAMA. 2001; 285:2486-97.
10. Vague J. The degree of masculine differentation of obesities. A factor determining predisposition to diabetes, atherosclerosis, gout, and acid uric calculous disease. Am J Clin Nutr. 1956;4:20-34.
11. Hills SA, Balkau B, Coppack SW, Dekker JM, Mari A, Natali A, et al. EGIR-RISC Study Group. The EGIR-RISC STUDY (the European Group for the Study of Insulin Resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives. Diabetologia. 2004;47:566-70.
12. Ford E, Giles W, Dietz W. Prevalence of the metabolic syndrome among adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-9.
13. Martínez Calatrava MJ, Martínez Larrad MT, Serrano Ríos M. Síndrome de resistencia a la insulina y síndrome metabólico: concepto, fisiopatología y epidemiología. Cardiovasc Risk Factors. 2003;12:89-95.
14. Álvarez León EE, Rivas Barba L, Serra Majem L. Prevalencia del síndrome metabólico en la población de la Comunidad Canaria. Med Clin (Barc). 2003;120:172-4.
15. Ascaso JF, Romero P, Real JT, Lorente RI, Martínez-Valls J, Carmen R. Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European population. Eur J Intern Med. 2003;14:101-6.
16. Álvarez Cosmea A, López Fernández V, Suárez García S, Arias García T, Prieto Díaz MA, Díaz González L. Diferencias en la prevalencia del síndrome metabólico según las definiciones del ATP-III y de la OMS. Med Clin (Barc) (en prensa).
17. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care. 2003;26:575-81.
18. Aguilar Salinas CA, Rojas R, Gómez Pérez FJ, Valles V, Rios Torres JM, Franco A. Analysis of the agreement between the World Health Organization Criteria and the National Colesterol Education Program-III definition of the metabolic syndrome. Diabetes Care. 2003;26:1635.
19. Carr DB, Utzschneider KM, Hull RL, Kodama K, Reztlaff BM, Brunzell JD, et al. Intraabdominal fat deposits is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes. 2004;53:2087-94.
20. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensibility in vivo. Endocr Rev. 1985;6:45-86.
21. Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care. 2003;26:3320-5.
22. Meigs JB. Metabolic syndrome. Diabetes Care. 2004;27:2761-3.